In this episode of the Women's Football Hub Podcast, host Carolyn Kent is joined by Dr Jessica Beal Stahl and sports pharmacist Emily Shears for a critical conversation about GLP-1 receptor agonists – better known as Ozempic, Wegovy, and Mounjaro. We unpack: How these drugs work in the body Why they were developed for diabetes and are now used more broadly (including PCOS, weight loss) Risks and side effects (appetite suppression, GI distress, nutrient depletion, ‘Ozempic teeth’, hormonal impacts) Black market concerns and safety issues Implications for female athletes (RED-S, sarcopenia, performance monitoring) Ethical and regulatory questions around sport This episode is essential for athletes, coaches, clinicians and anyone supporting female players. 🛒 Support the Hub by visiting www.womensfootballhub.com ⚠️ Disclaimer: This podcast is for informational purposes only and is not medical advice. Please consult a healthcare professional for personal guidance. #WomensFootballHub #FemaleAthleteHealth #GLP1 #Ozempic #Wegovy #Mounjaro #SportsPharmacy

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related